Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.
Journal: Cancer discovery
Published: June 28, 2024
A PROTAC degrader suppresses oncogenic functions of PTK6, inducing apoptosis of breast cancer cells.
A PROTAC degrader suppresses oncogenic functions of PTK6, inducing apoptosis of breast cancer cells.
Journal: Cell chemical biology
Published: August 28, 2023
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.
Journal: Cancer research communications
Published: February 20, 2023
CDK4: a master regulator of the cell cycle and its role in cancer.
Journal: Genes & cancer
Published: March 10, 2022
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.
Journal: Nature communications
Published: July 17, 2020
PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.
Journal: Breast cancer research : BCR
Published: November 19, 2019
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy.
Journal: Bioinformatics (Oxford, England)
Published: May 21, 2017
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.
Journal: NPJ breast cancer
Published: September 17, 2016
EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.
Journal: Oncotarget
Published: May 04, 2016
PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Journal: Breast cancer research : BCR
Published: January 20, 2016
Last Updated: 09/26/2026